RNAi zilebesiran add-on hypertensive; hypertension; KARDIA-2

Name: Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Uploaded: 2024-04-17T04:00:00+00:00
Duration: 3 min 45 s
Description: ACC.24 - Akshay Desai shares the findings of the phase 2 KARDIA-2 trial. “Treatment with zilebesiran seems to be an effective therapy to incrementally redu